Medtronic v. Colibri: Federal Circuit Reverses in Landmark Transcatheter Heart Valve Patent Dispute
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Medtronic, Inc. v. Colibri Heart Valve LLC |
| Case Number | 23-2153 (Fed. Cir.) |
| Court | Federal Circuit, Appeal from District Court |
| Duration | Jul 14, 2023 – Jul 18, 2025 2 years 0 months |
| Outcome | Defendant Win – Reversal |
| Patents at Issue | |
| Accused Products | Colibri’s percutaneous replacement heart valve technology and associated delivery system |
Case Overview
The Parties
⚖️ Plaintiff
One of the world’s largest medical device companies, with a dominant portfolio in cardiovascular technologies, including transcatheter aortic valve replacement (TAVR) systems.
🛡️ Defendant
A specialized medical device company focused on percutaneous heart valve replacement solutions, operating in a space dominated by larger incumbents.
Patents at Issue
This landmark case involved two patents covering percutaneous replacement heart valve technology — US9125739B2 and US8900294B2 — directed to a minimally invasive cardiac implant system that has reshaped interventional cardiology over the past decade.
- • US9125739B2 — Directed to a method of controlled release of a percutaneous replacement heart valve.
- • US8900294B2 — Directed to a percutaneous replacement heart valve and a delivery and implantation system.
Developing a similar medical device?
Check if your transcatheter valve design or method might infringe these or related patents.
The Verdict & Legal Analysis
Outcome
The Federal Circuit issued a clean reversal of the lower court’s decision. The court’s order — “THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: REVERSED” — indicates that the appellate panel found reversible error in the proceedings below. The case is designated closed, with the reversal serving as the basis of termination.
Key Legal Issues
At the Federal Circuit level, reversals in patent infringement cases most commonly arise from claim construction errors, sufficiency of evidence challenges, or legal errors in applying infringement doctrines. Given the patents cover both a structural device and a method of deployment, claim construction of functional and procedural limitations likely played a central role.
Filing a medical device patent?
Learn from this case. Use AI to draft stronger claims that can withstand litigation and appeal.
Power Your Patent Strategy with Eureka IP
From novelty searches to patent drafting, Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in transcatheter heart valve technology. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation for the TAVR market.
- View all related patents in this technology space
- See which companies are most active in TAVR patents
- Understand appellate claim construction patterns
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own medical device or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Percutaneous valve delivery methods & systems
2 Patents at Issue
Pivotal claims in device and method patents
Appellate Clarity
On specific claim term constructions
✅ Key Takeaways
For Patent Attorneys & Litigators
Federal Circuit reversals in medical device infringement cases often pivot on de novo claim construction – preserve all construction arguments for appeal.
Search related case law →Method claims covering clinical deployment steps require precise, evidence-supported infringement analysis at every litigation stage.
Explore precedents →For IP Professionals & R&D Teams
Patent portfolios in high-value device markets must be stress-tested for appellate claim construction vulnerability.
Start FTO analysis for my product →FTO clearance in the TAVR and structural heart space must be re-evaluated following appellate claim construction decisions.
Try AI patent drafting →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.